Medtech Fundraising Realities: What Founders Need to Know

At an LSI Europe emerging medtech summit, a panel of seasoned investors and medtech innovators convened to deliver a message medtech founders needed to hear: yes, it’s hard to raise capital right now — but there’s light at the end of the tunnel. The session, titled Light at the End of the Tunnel in Medtech Financing, provided a frank and tactical look at how to navigate today’s fundraising climate.


Visit here: https://medium.com/@lsieuropesummit/medtech-fundraising-realities-what-founders-need-to-know-b48daba65cbc


 

Comments

Post a Comment

Popular posts from this blog

The Global Stage for Live-Saving Innovation

Image
To date, LSI has hosted nine global summits — six in Southern California, three across Europe — and has welcomed more than 10,000 global executives. Too many events are light on real investors. That’s why we’ve built deep, lasting relationships with active VCs, PEs, and CVCs. and create an experience they show up for, year after year. We’re continuing to push the bar by bringing bold ideas and new capital into medtech. This year, we are thrilled to have Harry Stebbings, Founder of 20VC, join us to discuss lessons from the best founders, the AI landscape, and its impact on healthcare. Visit us here for more details:  https://www.lsieuropesummit.com/
Read more

The Art and Science of Cross-Border Business Development

Image
Cross-border business development in medtech is rarely a straight line. Between regulatory complexity, reimbursement variability, cultural nuances, and market-specific needs, expanding into new regions requires more than a product—it demands a strategy. At a recent LSI medtech conference in Europe, panelists Eliane Schutte (Xeltis), Jeffrey Sirek (PRIA Healthcare), Pieter Wijffels (NLC Health Ventures), and Sabine Kapasi (Enira Consulting), led by moderator Ajay Nair (The Mullings Group), tackled the topic head-on. Drawing from firsthand experience across Europe, the United States, China, India, and the Middle East, they explored what it takes to succeed in cross-border business development—from diligence and IP to commercialization, licensing, and culture. Visit here for more details: https://www.lsieuropesummit.com/news/the-art-and-science-of-cross-border-business-development
Read more